Endoscopic Retrograde Cholangiopancreatography Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Endoscopic Retrograde Cholangiopancreatography Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


Market Overview:

The global endoscopic retrograde cholangiopancreatography market size reached US$ 1.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.2 Billion by 2028, exhibiting a growth rate (CAGR) of 6.7% during 2023-2028.

Endoscopic retrograde cholangiopancreatography (ERCP) is an imaging technique that diagnoses and treats abnormalities in the liver, gallbladder, bile ducts, and pancreas. It combines X-rays and a long, flexible, lightweight endoscope tube that passes through the esophagus, mouth, and stomach. It helps detect blockages, stones, infections, and tumors in the bile duct and fluid leakage from the pancreatic duct. Besides this, it is a less invasive procedure than open surgery and provides more detailed and accurate information about the pancreaticobiliary system. As a result, the demand for endotherapy devices is increasing across the globe to investigate dysphagia, diarrhea, weight loss, heartburn, and stool blood.

Endoscopic Retrograde Cholangiopancreatography Market Trends:
The growing global population and the rising prevalence of various chronic gastrointestinal (GI) and incessant biliary medical disorders, including Barrett's disease, biliary, liver, Crohn's, inflammatory bowel, and peptic ulcer disease, and gastroesophageal reflux disorder (GERD), represent one of the key factors positively influencing the market. In addition, the increasing occurrence of benign pancreas and liver tumors, especially among the geriatric population, along with the growing occurrence of cancer across the globe, is driving the market. In line with this, the expansion of hospitals and diagnostic centers is increasing the need for imaging techniques propelling the market growth. Furthermore, rising investments by governments and healthcare organizations of various countries in advanced endoscopy devices and improve endoscopy research is strengthening the market growth. Apart from this, the shifting consumer preference toward minimally invasive surgeries for a speedy recovery and minimal pain and rising awareness about ERCP devices like sphincterotomes are offering a favorable market outlook. Moreover, continuous improvements in healthcare infrastructure and a considerable rise in medical tourism are expected to propel market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global endoscopic retrograde cholangiopancreatography market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, procedure and end user.

Breakup by Product:

Endoscope
Endotherapy Devices
Sphincterotomes
Lithotripter
Stents
Others
Visualization Systems
Energy Devices
Others

Breakup by Procedure:

Biliary Sphincterotomy
Biliary Stenting
Biliary Dialtation
Pancreatic Sphincterotomy
Pancreatic Duct Stenting
Pancreatic Duct Dilatation

Breakup by End User:

Hospitals and Clinics
Ambulatory Surgery Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Hobbs Medical Inc., Johnson & Johnson, Medi-Globe GmbH, Medtronic plc, Olympus Corporation, Shaili Endoscopy, Steris Corporation and Telemed Systems Inc.

Key Questions Answered in This Report

1. How big is the global endoscopic retrograde cholangiopancreatography market?
2. What is the expected growth rate of the global endoscopic retrograde cholangiopancreatography market during 2023-2028?
3. What are the key factors driving the global endoscopic retrograde cholangiopancreatography market?
4. What has been the impact of COVID-19 on the global endoscopic retrograde cholangiopancreatography market?
5. What is the breakup of the global endoscopic retrograde cholangiopancreatography market based on the product?
6. What is the breakup of the global endoscopic retrograde cholangiopancreatography market based on the procedure?
7. What is the breakup of the global endoscopic retrograde cholangiopancreatography market based on the end user?
8. What are the key regions in the global endoscopic retrograde cholangiopancreatography market?
9. Who are the key players/companies in the global endoscopic retrograde cholangiopancreatography market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Endoscopic Retrograde Cholangiopancreatography Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Endoscope
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Endotherapy Devices
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Sphincterotomes
6.2.2.2 Lithotripter
6.2.2.3 Stents
6.2.2.4 Others
6.2.3 Market Forecast
6.3 Visualization Systems
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Energy Devices
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Procedure
7.1 Biliary Sphincterotomy
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Biliary Stenting
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Biliary Dilatation
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Pancreatic Sphincterotomy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Pancreatic Duct Stenting
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Pancreatic Duct Dilatation
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgery Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Boston Scientific Corporation
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 CONMED Corporation
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Cook Group Incorporated
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Fujifilm Holdings Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Hobbs Medical Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Johnson & Johnson
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Medi-Globe GmbH
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Medtronic plc
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Olympus Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Shaili Endoscopy
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Steris Corporation
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Telemed Systems Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings